KEYTRUDA (PEMBROLIZUMAB)


KEYTRUDA (PEMBROLIZUMAB)

  • Adjuvant treatment of melanoma
  • Carcinoma of cervix
  • Endometrial carcinoma
  • Hodgkin's lymphoma
  • Liver cell carcinoma
  • Merkel cell carcinoma
  • Metastatic malignant melanoma
  • Microsatellite instability-high colorectal cancer
  • Microsatellite instability-high solid malignant tumor
  • Nonsquamous non-small cell lung cancer
  • Pd-l1 (+) adenocarcinoma of gastroesophageal junction
  • Pd-l1 positive adenocarcinoma of stomach
  • Pd-l1 positive cervical cancer
  • Pd-l1 positive non-small cell lung cancer
  • Pd-l1 positive squamous cell carcinoma of esophagus
  • Primary mediastinal large b-cell lymphoma
  • Renal cell carcinoma
  • Small cell lung carcinoma
  • Squamous cell carcinoma of head and neck
  • Squamous cell carcinoma of lung
  • Transitional cell carcinoma of the urinary tract